Why Illumina Stock Got Mashed on Monday
On Monday, for the second time in as many business days, Illumina (NASDAQ: ILMN) stock took it on the chin because of an ...
Illumina cut to underweight by Barclays, China woes cited
Illumina (NASDAQ:ILMN) has been cut to underweight from equal weight by Barclays over concerns the company may be facing sanctions in China and risks to its 2025 and long-range guidance. "Given our ...
6ILMN : Decoding Illumina's Options Activity: What's the...
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...
10x Genomics price target lowered to $18 from $19 at Barclays
Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...
Illumina (NASDAQ:ILMN) Price Target Cut to $130.00 by Analysts at Barclays
Illumina (NASDAQ:ILMN – Free Report) had its target price trimmed by Barclays from $145.00 to $130.00 in a research report report published on Monday morning,Benzinga reports. The brokerage currently ...